Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia

Ishimoto H., Mukae H., Date Y., Shimbara T., Mondal M. S., Ashitani J., Hiratsuka T., Kubo S., Kohno S., Nakazato M.

Source: Eur Respir J 2006; 27: 253-260
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ishimoto H., Mukae H., Date Y., Shimbara T., Mondal M. S., Ashitani J., Hiratsuka T., Kubo S., Kohno S., Nakazato M.. Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur Respir J 2006; 27: 253-260

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum levels of LTB4 are increased in patients with lower respiratory tract infection (LRTI) caused by Mycoplasma pneumoniae
Source: Eur Respir J 2001; 18: Suppl. 33, 542s
Year: 2001

Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002



Fluoroquinolones and lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94
Year: 2004

The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 825s
Year: 2006

Role of α- and β-defensins in lower respiratory tract infections
Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections
Year: 2007


Lower respiratory tract infections: bacteria and virus, antibiotics and steroids
Source: Annual Congress 2008 - Infection year in review
Year: 2008


Seasonal distribution of acute respiratory tract infections (RTIs) due to respiratory syncytial virus (RSV), to Mycoplasma pneumonia (MP) and to Chlamydia pneumonia (CP)
Source: Eur Respir J 2001; 18: Suppl. 33, 234s
Year: 2001

Macrolides and lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=78
Year: 2004

Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis
Source: Eur Respir J 2003; 21: 939-943
Year: 2003



Quantitative culture of sputum in respiratory tract infections in Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 643s
Year: 2004

Procalcitonin (PCT) as a diagnostic tool in lower respiratory tract infections (LRTI) and TB
Source: Eur Respir J 2001; 18: Suppl. 33, 542s
Year: 2001

Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection
Source: Eur Respir J 2011; 37: 119-125
Year: 2011



The role of atypical pathogens in the respiratory failure caused by lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

Antibody deficiency in adults with recurrent respiratory tract infections
Source: Eur Respir J 2001; 18: Suppl. 33, 106s
Year: 2001

Urinary antigen of S. pneumoniae in the microbiological diagnosis of lower respiratory tract infections
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


The role of respiratory viruses in the respiratory failure caused by lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 516s
Year: 2003

Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Time-course of upper respiratory tract viral infection and COPD exacerbation
Source: Eur Respir J, 54 (4) 1900407; 10.1183/13993003.00407-2019
Year: 2019